Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial.
Hayashida T, Jinno H, Mori K, Sato H, Matsui A, Sakurai T, Hattori H, Takayama S, Wada M, Takahashi M, Seki H, Seki T, Nagayama A, Matsumoto A, Kitagawa Y. Hayashida T, et al. Among authors: matsumoto a. BMC Cancer. 2018 Jun 28;18(1):701. doi: 10.1186/s12885-018-4628-7. BMC Cancer. 2018. PMID: 29954362 Free PMC article. Clinical Trial.
Biological markers of invasive breast cancer.
Matsumoto A, Jinno H, Ando T, Fujii T, Nakamura T, Saito J, Takahashi M, Hayashida T, Kitagawa Y. Matsumoto A, et al. Jpn J Clin Oncol. 2016 Feb;46(2):99-105. doi: 10.1093/jjco/hyv153. Epub 2015 Oct 20. Jpn J Clin Oncol. 2016. PMID: 26486826 Review.
3,262 results